(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PHILATOM INNOVATION OF NANOCEUTICALS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

PHILATOM INNOVATION OF NANOCEUTICALS

ST13

US500000088823885

Classe

5

Pedido

88823885

Registro

7805894

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

74

Atualização mais recente

27/05/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

06/03/2020

Data de registro

27/05/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/05/2025

Última transação

27/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

3

Tipo de titular

03

Localização do titular

Markham, Ontario, CA

Examinador

O'BRIEN, JENNIFER

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of a depiction of a pill containing representations of molecules. The depiction of the pill is tilted to the right and the top is disconnected from the bottom. Beneath the depiction of the pill is a representation of a shadow of said pill. To the right of the pill depiction is the text "PHILATOM" appearing in stylized font. Below, appears the text "INNOVATION OF NANOCEUTICALS" in stylized font.

Titulares e representantes

Titulares

NUTRICAN INC.

Representantes

Ran He

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Nutritional supplements consisting primarily of calcium and Omega-3 fatty acids and monoglycerides supplements

Publicações

Histórico de despachos e eventos da marca no USPTO.

74 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

27/05/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/04/2025

PUBO

PUBLISHED FOR OPPOSITION

08/04/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/04/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

30/01/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

28/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/12/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/12/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/12/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/12/2024

GNRT

NON-FINAL ACTION E-MAILED

12/12/2024

CNRT

NON-FINAL ACTION WRITTEN

12/12/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/10/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

28/10/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

19/03/2024

GNSL

LETTER OF SUSPENSION E-MAILED

19/03/2024

CNSL

SUSPENSION LETTER WRITTEN

19/03/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/03/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

14/03/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

21/12/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

21/12/2023

CNSI

SUSPENSION INQUIRY WRITTEN

21/12/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

14/12/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

25/03/2023

GNSL

LETTER OF SUSPENSION E-MAILED

25/03/2023

CNSL

SUSPENSION LETTER WRITTEN

25/03/2023

DOCK

ASSIGNED TO EXAMINER

01/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/01/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

17/01/2023

ALIE

ASSIGNED TO LIE

17/01/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/01/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

02/08/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

02/08/2022

CNSI

SUSPENSION INQUIRY WRITTEN

02/08/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/02/2022

GNSL

LETTER OF SUSPENSION E-MAILED

01/02/2022

CNSL

SUSPENSION LETTER WRITTEN

01/02/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/01/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/01/2022

GAUN

NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

27/09/2021

GAUD

NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

27/09/2021

NAUD

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

27/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/09/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

20/09/2021

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

18/09/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

18/09/2021

CNSI

SUSPENSION INQUIRY WRITTEN

18/09/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/08/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

20/08/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/08/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/08/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

18/03/2021

GNSL

LETTER OF SUSPENSION E-MAILED

18/03/2021

CNSL

SUSPENSION LETTER WRITTEN

18/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/03/2021

ALIE

ASSIGNED TO LIE

16/03/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

14/12/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

02/12/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

02/12/2020

CNSI

SUSPENSION INQUIRY WRITTEN

02/12/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

28/05/2020

GNSL

LETTER OF SUSPENSION E-MAILED

28/05/2020

CNSL

SUSPENSION LETTER WRITTEN

28/05/2020

DOCK

ASSIGNED TO EXAMINER

27/05/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

13/03/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/03/2020

NWAP

NEW APPLICATION ENTERED

10/03/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PHILATOM INNOVATION OF NANOCEUTICALS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.